Maternal hormonal milieu influence on fetal brain development
- PMID: 29484271
- PMCID: PMC5822586
- DOI: 10.1002/brb3.920
Maternal hormonal milieu influence on fetal brain development
Abstract
An adverse maternal hormonal environment during pregnancy can be associated with abnormal brain growth. Subtle changes in fetal brain development have been observed even for maternal hormone levels within the currently accepted physiologic ranges. In this review, we provide an update of the research data on maternal hormonal impact on fetal neurodevelopment, giving particular emphasis to thyroid hormones and glucocorticoids. Thyroid hormones are required for normal brain development. Despite serum TSH appearing to be the most accurate indicator of thyroid function in pregnancy, maternal serum free T4 levels in the first trimester of pregnancy are the major determinant of postnatal psychomotor development. Even a transient period of maternal hypothyroxinemia at the beginning of neurogenesis can confer a higher risk of expressive language and nonverbal cognitive delays in offspring. Nevertheless, most recent clinical guidelines advocate for targeted high-risk case finding during first trimester of pregnancy despite universal thyroid function screening. Corticosteroids are determinant in suppressing cell proliferation and stimulating terminal differentiation, a fundamental switch for the maturation of fetal organs. Not surprisingly, intrauterine exposure to stress or high levels of glucocorticoids, endogenous or synthetic, has a molecular and structural impact on brain development and appears to impair cognition and increase anxiety and reactivity to stress. Limbic regions, such as hippocampus and amygdala, are particularly sensitive. Repeated doses of prenatal corticosteroids seem to have short-term benefits of less respiratory distress and fewer serious health problems in offspring. Nevertheless, neurodevelopmental growth in later childhood and adulthood needs further clarification. Future studies should address the relevance of monitoring the level of thyroid hormones and corticosteroids during pregnancy in the risk stratification for impaired postnatal neurodevelopment.
Keywords: fetal neurodevelopment; fetal programming; glucocorticoids; maternal hormones; melatonin; oxytocin; sex steroids; thyroid hormones.
Figures
References
-
- Abbasi, S. , Hirsch, D. , Davis, J. , Tolosa, J. , Stouffer, N. , Debbs, R. , & Gerdes, J. S. (2000). Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. American Journal of Obstetrics and Gynecology, 182, 1243–1249. https://doi.org/10.1067/mob.2000.104789 - DOI - PubMed
-
- ACOG (2016). ACOG Practice Advisory: Antenatal Corticosteroid Administration in the Late Preterm Period.
-
- Ahlquist, J. A. , Franklyn, J. A. , Ramsden, D. B. , & Sheppard, M. C. (1989). The influence of dexamethasone on serum thyrotrophin and thyrotrophin synthesis in the rat. Molecular and Cellular Endocrinology, 64, 55–61. https://doi.org/10.1016/0303-7207(89)90064-6 - DOI - PubMed
-
- Ahmed, O. M. , Ahmed, R. G. , El‐Gareib, A. W. , El‐Bakry, A. M. , & Abd El‐Tawab, S. M. (2012). Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II‐the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system. International Journal of Developmental Neuroscience, 30, 517–537. https://doi.org/10.1016/j.ijdevneu.2012.04.005 - DOI - PubMed
-
- Alexander, E. K. , Pearce, E. N. , Brent, G. A. , Brown, R. S. , Chen, H. , Dosiou, C. , … Sullivan, S. (2017). 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27, 315–389. https://doi.org/10.1089/thy.2016.0457 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
